Rheumatoid Arthritis eJournal Club
   

Rheumatoid Arthritis: The Heart of the Matter Assessing
Cardiovascular Risk in Patients with Rheumatoid Arthritis
 
Release Date: April 16, 2009 Expiration Date: April 16, 2010

Technical Requirements
(will appear in new window)
 
Estimated Time of Completion 60 minutes
Description / Overview The purpose of this activity is to review the assessment and management of cardiovascular disease in patients with rheumatoid arthritis (RA).
Objectives On completion of this activity, participants should be able to:
  1. Describe the epidemiology of cardiovascular disease in patients with RA.
  2. Identify and assess the risk factors contributing to the risk of cardiovascular disease in patients with RA.
  3. Discuss management strategies which may attenuate the risk of cardiovascular disease in patients with RA.
Target Audience This activity is directed to rheumatologists and primary care physicians who treat patients with RA.
Accreditation The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Activity Director Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Vice Chairman
Department of Rheumatic & Immunologic Diseases
R.J. Fasenmyer Chair of Clinical Immunology
Cleveland Clinic
Cleveland, Ohio
Author / Faculty M. Elaine Husni, MD, MPH
Assistant Professor
Cleveland Clinic Lerner College of Medicine of
   Case Western Reserve University
Vice Chair of Rheumatology and Director
Arthritis and Musculoskeletal Center
Staff Physician
Orthopedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, Ohio
Faculty Disclosure In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty has indicated that he may have a relationship, which in the context of his presentation(s), could be perceived as a potential conflict of interest:
Leonard Calabrese, DO
  Consulting: Abbott Laboratories;
Elan Pharmaceuticals, Inc.;
Genentech, Inc.; Roche Laboratories, Inc.
 
  Teaching and Speaking: Genentech, Inc.

The following faculty member has indicated that she has no relationship which, in the context of her presentation, could be perceived as a potential conflict of interest:

M. Elaine Husni, MD, MPH

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of this activity from:

Bristol – Myers Squibb Company, Genentech/Biogen Idec

Wyeth Pharmaceuticals

This CME activity was produced by The Cleveland Clinic Foundation
Center for Continuing Education and DIME.

CME Disclaimer